FDA Inspection 942102 — IPR Pharmaceuticals, Inc.

IPR Pharmaceuticals, Inc. — FEI 3003009422

The FDA completed an inspection of IPR Pharmaceuticals, Inc. on August 26, 2015 in Canovanas, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 26, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Canovanas, PR (United States)